Internal Medicine, Transplant Hepatology · Charleston, SC
NPI
1396853255
Since 2006
Specialty
Internal Medicine, Transplant Hepatology
Code 207RT0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
171 Ashley Ave
Charleston, SC, 29425
Phone (843) 792-1414
Groups this clinician bills Medicare through
Medicare paid, 2024
$57K
1,121 services
Medicare patients, 2024
418
Average age 70
Drug cost, 2024
$1.4M
2,227 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ira R Willner was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 335 times for 236 patients. In total Ira R Willner billed 1,121 services in 28 codes, and Medicare paid $57K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-03-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 335 | 236 | $11.94 | $4,002 |
| 99214 Office E&M - Established | Facility | 331 | 241 | $64.99 | $22K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 62 | 50 | $12.09 | $749 |
| 99213 Office E&M - Established | Facility | 62 | 57 | $42.39 | $2,628 |
| 99233 Hospital E&M - Subsequent | Facility | 52 | 15 | $88.81 | $4,618 |
| 99232 Hospital E&M - Subsequent | Facility | 45 | 24 | $59.04 | $2,657 |
| 99214 Office E&M - Established | Office | 39 | 30 | $85.78 | $3,345 |
| 99213 Office E&M - Established | Office | 35 | 32 | $63.43 | $2,220 |
| 99204 Office E&M - New | Facility | 29 | 29 | $99.50 | $2,886 |
| 99215 Office E&M - Established | Facility | 27 | 23 | $92.82 | $2,506 |
| 99222 Hospital E&M - Initial | Facility | 20 | 20 | $97.45 | $1,949 |
| 99205 Office E&M - New | Facility | 15 | 15 | $135.35 | $2,030 |
| 99223 Hospital E&M - Initial | Facility | 13 | 12 | $129.28 | $1,681 |
By year: 2022 $74K for 1,152 services; 2023 $64K for 1,177 services; 2024 $57K for 1,121 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ira R Willner prescribed most often to Medicare patients was Tacrolimus, with 486 prescriptions and refills. In total Ira R Willner wrote 2,227 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tacrolimus Generic | 486 | 1,027 | 105 | $78K |
| Xifaxan Rifaximin | 348 | 348 | 55 | $1.0M |
| Mycophenolate Mofetil Generic | 186 | 406 | 47 | $24K |
| Ursodiol Generic | 98 | 196 | 22 | $19K |
| Furosemide Generic | 74 | 177 | 30 | $356 |
| Pantoprazole Sodium Generic | 73 | 170 | 21 | $1,133 |
| Spironolactone Generic | 67 | 118 | 25 | $1,033 |
| Carvedilol Generic | 61 | 141 | 18 | $593 |
| Entecavir Generic | 55 | 119 | Under 11 | $19K |
| Cyclosporine Modified Cyclosporine, Modified | 54 | 147 | 15 | $14K |
| Omeprazole Generic | 53 | 139 | 17 | $864 |
| Azathioprine Generic | 48 | 112 | 11 | $1,886 |
| Prednisone Generic | 47 | 79 | 12 | $347 |
| Famotidine Generic | 45 | 107 | Under 11 | $993 |
| Vemlidy Tenofovir Alafenamide | 43 | 43 | Under 11 | $56K |
Brand drugs: 538 claims; generic drugs: 1,689 claims; opioid claims: 23.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ira R Willner were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.